JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB115793

Anti-Aurora B (phospho T232) antibody

0

(3 Reviews)

|

(5 Publications)

Rabbit Polyclonal Aurora B phospho T232 antibody. Suitable for IHC-P and reacts with Human samples. Cited in 5 publications. Immunogen corresponding to Synthetic Peptide within Human AURKB phospho T232.

View Alternative Names

AIK2, AIM1, AIRK2, ARK2, STK1, STK12, STK5, AURKB, Aurora kinase B, Aurora 1, Aurora- and IPL1-like midbody-associated protein 1, Aurora/IPL1-related kinase 2, STK-1, Serine/threonine-protein kinase 12, Serine/threonine-protein kinase 5, Serine/threonine-protein kinase aurora-B, AIM-1, ARK-2, Aurora-related kinase 2

2 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Aurora B (phospho T232) antibody (AB115793)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Aurora B (phospho T232) antibody (AB115793)

Immunohistochemical analysis of paraffin embedded Human skin tissue labeling Aurora B (phospho T232) with ab115793 at 5 ug/ml.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Aurora B (phospho T232) antibody (AB115793)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Aurora B (phospho T232) antibody (AB115793)

Immunohistochemical analysis of paraffin embedded Human adrenal tissue labeling Aurora B (phospho T232) with ab115793 at 5 ug/ml.

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IHC-P

applications

Immunogen

Synthetic Peptide within Human AURKB phospho T232. The exact immunogen used to generate this antibody is proprietary information.

Q96GD4

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "5 µg/mL", "IHCP-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
Preservative: 0.09% Sodium azide Constituents: 50% Glycerol (glycerin, glycerine), 49% PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Aurora B also known as Aurora kinase B or AURKB is a serine/threonine protein kinase with a molecular mass of approximately 39 kDa. This protein expresses across various cell types and tissues playing a critical role during cell division. It localizes to the centromeres during early mitosis and later associates with the central spindle and midbody. Aurora B is a component of the chromosomal passenger complex (CPC) which includes other proteins such as INCENP survivin and borealin essential for its function.
Biological function summary

Aurora B kinase functions to ensure proper chromosome alignment segregation and cytokinesis during mitosis and meiosis. It phosphorylates various substrates to facilitate processes like correction of kinetochore-microtubule attachments and regulation of the mitotic checkpoint. As a part of the CPC Aurora B acts in coordination with other proteins to control these cellular events ensuring that cells divide accurately and safely.

Pathways

Aurora B integrates into the cell cycle and mitotic pathways operating closely with the spindle assembly checkpoint. It interacts with proteins like CENP-A and CENP-E ensuring error-free chromosome segregation. Aurora B's activity within these pathways is critical for maintaining genomic stability and preventing aneuploidy a condition linked to improper chromosome number.

Aurora B's malfunction associates with cancer and chromosomal instability. Overexpression or dysregulation of Aurora B kinase frequently occurs in several types of cancer contributing to tumorigenesis by promoting abnormal cell division. Proteins such as p53 a well-known tumor suppressor often become functionally compromised when Aurora B activity is altered further advancing disease progression. Aurora B also holds implications in other disorders marked by faulty cell cycle regulation emphasizing its potential as a therapeutic target.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Serine/threonine-protein kinase component of the chromosomal passenger complex (CPC), a complex that acts as a key regulator of mitosis (PubMed : 11516652, PubMed : 12925766, PubMed : 14610074, PubMed : 14722118, PubMed : 29449677). The CPC complex has essential functions at the centromere in ensuring correct chromosome alignment and segregation and is required for chromatin-induced microtubule stabilization and spindle assembly (PubMed : 11516652, PubMed : 12925766, PubMed : 14610074, PubMed : 14722118, PubMed : 26829474). Involved in the bipolar attachment of spindle microtubules to kinetochores and is a key regulator for the onset of cytokinesis during mitosis (PubMed : 15249581). Required for central/midzone spindle assembly and cleavage furrow formation (PubMed : 12458200, PubMed : 12686604). Key component of the cytokinesis checkpoint, a process required to delay abscission to prevent both premature resolution of intercellular chromosome bridges and accumulation of DNA damage : phosphorylates CHMP4C, leading to retain abscission-competent VPS4 (VPS4A and/or VPS4B) at the midbody ring until abscission checkpoint signaling is terminated at late cytokinesis (PubMed : 22422861, PubMed : 24814515). AURKB phosphorylates the CPC complex subunits BIRC5/survivin, CDCA8/borealin and INCENP (PubMed : 11516652, PubMed : 12925766, PubMed : 14610074). Phosphorylation of INCENP leads to increased AURKB activity (PubMed : 11516652, PubMed : 12925766, PubMed : 14610074). Other known AURKB substrates involved in centromeric functions and mitosis are CENPA, DES/desmin, GPAF, KIF2C, NSUN2, RACGAP1, SEPTIN1, VIM/vimentin, HASPIN, and histone H3 (PubMed : 11756469, PubMed : 11784863, PubMed : 11856369, PubMed : 12689593, PubMed : 14602875, PubMed : 16103226, PubMed : 21658950). A positive feedback loop involving HASPIN and AURKB contributes to localization of CPC to centromeres (PubMed : 21658950). Phosphorylation of VIM controls vimentin filament segregation in cytokinetic process, whereas histone H3 is phosphorylated at 'Ser-10' and 'Ser-28' during mitosis (H3S10ph and H3S28ph, respectively) (PubMed : 11784863, PubMed : 11856369). AURKB is also required for kinetochore localization of BUB1 and SGO1 (PubMed : 15020684, PubMed : 17617734). Phosphorylation of p53/TP53 negatively regulates its transcriptional activity (PubMed : 20959462). Key regulator of active promoters in resting B- and T-lymphocytes : acts by mediating phosphorylation of H3S28ph at active promoters in resting B-cells, inhibiting RNF2/RING1B-mediated ubiquitination of histone H2A and enhancing binding and activity of the USP16 deubiquitinase at transcribed genes (By similarity). Acts as an inhibitor of CGAS during mitosis : catalyzes phosphorylation of the N-terminus of CGAS during the G2-M transition, blocking CGAS liquid phase separation and activation, and thereby preventing CGAS-induced autoimmunity (PubMed : 33542149). Phosphorylates KRT5 during anaphase and telophase (By similarity). Phosphorylates ATXN10 which promotes phosphorylation of ATXN10 by PLK1 and may play a role in the regulation of cytokinesis and stimulating the proteasomal degradation of ATXN10 (PubMed : 25666058).
See full target information AURKB phospho T232

Publications (5)

Recent publications for all applications. Explore the full list and refine your search

Clinical Medicine Insights. Oncology 17:11795549231180832 PubMed37359274

2023

A Tumor Suppressive Role of CYLD as a Novel Potential DUB of Aurora B in Cervical Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Yufan Huang,Wei Zhang,Zhihui Yu,Hongkai Su,Bin Zeng,Jinsong Piao,Jing Wang,Juan Wu

Cell death & disease 12:152 PubMed33542222

2021

Targeting Aurora B kinase with Tanshinone IIA suppresses tumor growth and overcomes radioresistance.

Applications

Unspecified application

Species

Unspecified reactive species

Ming Li,Haidan Liu,Qin Zhao,Shuangze Han,Li Zhou,Wenbin Liu,Wei Li,Feng Gao

Cell death discovery 7:16 PubMed33462217

2021

Inhibition of Aurora Kinase B activity disrupts development and differentiation of salivary glands.

Applications

Unspecified application

Species

Unspecified reactive species

Abeer K Shaalan,Tathyane H N Teshima,Abigail S Tucker,Gordon B Proctor

American journal of cancer research 10:3666-3685 PubMed33294260

2020

Chiauranib selectively inhibits colorectal cancer with wild-type by modulation of ROS through activating the p53 signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Haofan Yin,Jinye Xie,Ping Jiang,Xi Jiang,Deyu Duan,Junhua Qi,Zhaofan Luo,Caiqi Ma,Honghai Hong

Oncotarget 6:35173-82 PubMed26460953

2015

PRMT1 promotes mitosis of cancer cells through arginine methylation of INCENP.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaolan Deng,Gottfried Von Keudell,Takehiro Suzuki,Naoshi Dohmae,Makoto Nakakido,Lianhua Piao,Yuichiro Yoshioka,Yusuke Nakamura,Ryuji Hamamoto
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Associated Products

Select an associated product type
Alternative Product
Primary Antibodies

AB218339

Anti-Aurora B antibody [AURKB/1521]

primary-antibodies

aurora-b-antibody-aurkb-1521-ab218339

0

(0 reviews)

Alternative Product
Primary Antibodies

AB3609

Anti-Aurora B antibody [mAbcam 3609]

primary-antibodies

aurora-b-antibody-mabcam-3609-ab3609

5

(5 reviews)

Alternative Product
Primary Antibodies

AB2254

Anti-Aurora B antibody

primary-antibodies

aurora-b-antibody-ab2254

4

(36 reviews)

Alternative Product
Primary Antibodies

AB210706

Anti-Aurora B (phospho S227) antibody [EPR20389]

primary-antibodies

aurora-b-phospho-s227-antibody-epr20389-ab210706

4

(1 reviews)

Alternative Product
Primary Antibodies

AB45145

Anti-Aurora B antibody [EP1009Y]

primary-antibodies

aurora-b-antibody-ep1009y-ab45145

4

(1 reviews)

Alternative Product
Primary Antibodies

AB239837

Anti-Aurora B antibody [EP1009Y] - BSA and Azide free

primary-antibodies

aurora-b-antibody-ep1009y-bsa-and-azide-free-ab239837

0

(0 reviews)

Alternative Product
Primary Antibodies

AB269754

Anti-Aurora B antibody [AURKB/1521] - BSA and Azide free

primary-antibodies

aurora-b-antibody-aurkb-1521-bsa-and-azide-free-ab269754

0

(0 reviews)

Alternative Product
Primary Antibodies

AB197614

Alexa Fluor® 647 Anti-Aurora B antibody [EP1009Y]

primary-antibodies

alexa-fluor-647-aurora-b-antibody-ep1009y-ab197614

0

(0 reviews)

Alternative Product
Primary Antibodies

AB70238

Anti-Aurora B antibody

primary-antibodies

aurora-b-antibody-ab70238

0

(0 reviews)

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com